Literature DB >> 22214556

Fructose 2,6-bisphosphate is essential for glucose-regulated gene transcription of glucose-6-phosphatase and other ChREBP target genes in hepatocytes.

Catherine Arden1, Susan J Tudhope, John L Petrie, Ziad H Al-Oanzi, Kirsty S Cullen, Alex J Lange, Howard C Towle, Loranne Agius.   

Abstract

Glucose metabolism in the liver activates the transcription of various genes encoding enzymes of glycolysis and lipogenesis and also G6pc (glucose-6-phosphatase). Allosteric mechanisms involving glucose 6-phosphate or xylulose 5-phosphate and covalent modification of ChREBP (carbohydrate-response element-binding protein) have been implicated in this mechanism. However, evidence supporting an essential role for a specific metabolite or pathway in hepatocytes remains equivocal. By using diverse substrates and inhibitors and a kinase-deficient bisphosphatase-active variant of the bifunctional enzyme PFK2/FBP2 (6-phosphofructo-2-kinase-fructose-2,6-bisphosphatase), we demonstrate an essential role for fructose 2,6-bisphosphate in the induction of G6pc and other ChREBP target genes by glucose. Selective depletion of fructose 2,6-bisphosphate inhibits glucose-induced recruitment of ChREBP to the G6pc promoter and also induction of G6pc by xylitol and gluconeogenic precursors. The requirement for fructose 2,6-bisphosphate for ChREBP recruitment to the promoter does not exclude the involvement of additional metabolites acting either co-ordinately or at downstream sites. Glucose raises fructose 2,6-bisphosphate levels in hepatocytes by reversing the phosphorylation of PFK2/FBP2 at Ser32, but also independently of Ser32 dephosphorylation. This supports a role for the bifunctional enzyme as the phosphometabolite sensor and for its product, fructose 2,6-bisphosphate, as the metabolic signal for substrate-regulated ChREBP-mediated expression of G6pc and other ChREBP target genes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22214556     DOI: 10.1042/BJ20111280

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  HCF-1 Regulates De Novo Lipogenesis through a Nutrient-Sensitive Complex with ChREBP.

Authors:  Elizabeth A Lane; Dong Wook Choi; Luisa Garcia-Haro; Zebulon G Levine; Meghan Tedoldi; Suzanne Walker; Nika N Danial
Journal:  Mol Cell       Date:  2019-06-18       Impact factor: 17.970

Review 2.  Changing appetites: the adaptive advantages of fuel choice.

Authors:  Illana A Stanley; Sofia M Ribeiro; Alfredo Giménez-Cassina; Erik Norberg; Nika N Danial
Journal:  Trends Cell Biol       Date:  2013-09-07       Impact factor: 20.808

Review 3.  Hepatic glucose sensing and integrative pathways in the liver.

Authors:  Maaike H Oosterveer; Kristina Schoonjans
Journal:  Cell Mol Life Sci       Date:  2013-11-07       Impact factor: 9.261

Review 4.  Glucokinase Activators for Type 2 Diabetes: Challenges and Future Developments.

Authors:  Konstantinos A Toulis; Krishnarajah Nirantharakumar; Chrysa Pourzitaki; Anthony H Barnett; Abd A Tahrani
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

Review 5.  Coordination of nutrient availability and utilization by MAX- and MLX-centered transcription networks.

Authors:  John M O'Shea; Donald E Ayer
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

6.  Cyclin D1 in the Liver: Role of Noncanonical Signaling in Liver Steatosis and Hormone Regulation.

Authors:  Kelley G Núñez; Janet Gonzalez-Rosario; Paul T Thevenot; Ari J Cohen
Journal:  Ochsner J       Date:  2017

7.  ChREBP regulates fructose-induced glucose production independently of insulin signaling.

Authors:  Mi-Sung Kim; Sarah A Krawczyk; Ludivine Doridot; Alan J Fowler; Jennifer X Wang; Sunia A Trauger; Hye-Lim Noh; Hee Joon Kang; John K Meissen; Matthew Blatnik; Jason K Kim; Michelle Lai; Mark A Herman
Journal:  J Clin Invest       Date:  2016-09-26       Impact factor: 14.808

8.  Glucose induces protein targeting to glycogen in hepatocytes by fructose 2,6-bisphosphate-mediated recruitment of MondoA to the promoter.

Authors:  John L Petrie; Ziad H Al-Oanzi; Catherine Arden; Susan J Tudhope; Jelena Mann; Julius Kieswich; Muhammad M Yaqoob; Howard C Towle; Loranne Agius
Journal:  Mol Cell Biol       Date:  2012-12-03       Impact factor: 4.272

9.  Low metformin causes a more oxidized mitochondrial NADH/NAD redox state in hepatocytes and inhibits gluconeogenesis by a redox-independent mechanism.

Authors:  Ahmed Alshawi; Loranne Agius
Journal:  J Biol Chem       Date:  2018-12-27       Impact factor: 5.157

Review 10.  Energy metabolism in the liver.

Authors:  Liangyou Rui
Journal:  Compr Physiol       Date:  2014-01       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.